The Impact of Targeted Estrogen Receptor (ER) Imaging on Breast Cancer Patients

Register Online

Leading healthcare experts Dr. Hannah Linden and Dr. Gary Ulaner will offer their insights about a diagnostic imaging agent that may help inform physicians clinical decisions and treatment selection for people with recurrent or metastatic breast cancer.

Screenshot-2022-08-16-144852Dr. Gary Ulaner, Director, Molecular Imaging and Therapy at the Hoag Family Cancer Institute.
Screenshot-2022-09-16-153503Dr. Hannah Linden, Clinical Director of the Breast Cancer Program at the University of Washington/Fred Hutchinson Cancer Center.


Register to get instructions to join.

Wednesday, 3-4pm ET
Oct 19

Register Online

National Helpline: